Managing Lupus Nephritis in Children and Adolescents

Area of Science:

• Pediatric Nephrology
• Rheumatology
• Immunology

Background:

• Lupus nephritis (LN) is a severe complication of systemic lupus erythematosus (SLE), frequently leading to chronic kidney disease and mortality.
• Pediatric SLE patients have a high incidence of LN (35-60%), impacting long-term health outcomes.
• Despite treatment advances, high-level evidence for managing childhood-onset LN is limited due to small patient cohorts and trial exclusions.

Purpose of the Study:

• To review the current management strategies for childhood-onset lupus nephritis.
• To highlight the distinct clinical, therapeutic, and psychosocial considerations in pediatric LN compared to adult-onset disease.
• To provide an updated perspective on the 'art and science' of managing pediatric LN.

Main Methods:

• Review of existing literature on childhood-onset lupus nephritis.
• Analysis of differences in disease presentation, treatment response, and tolerance between pediatric and adult patients.
• Synthesis of current clinical management guidelines and emerging therapeutic approaches.

Main Results:

• Outcomes for LN patients have improved with immunosuppressive therapies and better clinical management.
• Significant differences exist between childhood- and adult-onset LN regarding disease severity, treatment efficacy, medication tolerance, and psychosocial impact.
• Management requires tailored approaches considering the unique developmental and physiological aspects of children and adolescents.

Conclusions:

• Managing childhood-onset lupus nephritis requires specialized knowledge beyond adult protocols.
• Addressing the unique disease characteristics and psychosocial needs of pediatric patients is crucial for optimal outcomes.
• Continued research and pediatric-specific clinical trials are essential to advance evidence-based care for childhood LN.